Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis: A Multicenter Double-Blind Randomized Controlled Trail

Table 3

Efficacy of FZHY on ALT, AST, HA, and Child-Pugh score in HBC.

Index	Treatment	FZHY group	Placebo group	P value
		(mean ± SD)	(mean ± SD)
		(𝑛=75)	(𝑛=72)
ALT (U/L)	Before	49.96±47.29	46.38±33.07	0.5996
	After	39.74±26.48	39.97±29.44	0.9602
	P value	0.1088	0.2229
AST (U/L)	Before	57.69±44.96	58.89±42.92	0.8700
	After	50.53±33.40	47.36±28.94	0.5421
	P value	0.2757	0.0614
HA (ng/mL)	Before	219.88±193.08	194.28±155.21	0.3969
	After	140.35±104.02	171.66±156.99	0.1613
	P value	0.0026	0.3980
Child-Pugh (score)	Before	5.45±0.99	5.86±1.43	0.0468
	After	5.46±0.90	5.57±1.22	0.5354
	P value	0.9746	0.1939